Compare GIPR & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GIPR | INBS |
|---|---|---|
| Founded | 2015 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4M | 6.4M |
| IPO Year | 2021 | N/A |
| Metric | GIPR | INBS |
|---|---|---|
| Price | $0.59 | $5.02 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 50.5K | ★ 128.0K |
| Earning Date | 03-31-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $9,953,920.00 | $3,581,322.00 |
| Revenue This Year | $1.12 | $778.48 |
| Revenue Next Year | $0.52 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 18.14 |
| 52 Week Low | $0.54 | $4.03 |
| 52 Week High | $2.06 | $27.50 |
| Indicator | GIPR | INBS |
|---|---|---|
| Relative Strength Index (RSI) | 39.76 | 34.64 |
| Support Level | $0.54 | $8.03 |
| Resistance Level | $0.70 | $7.40 |
| Average True Range (ATR) | 0.05 | 0.72 |
| MACD | -0.01 | -0.58 |
| Stochastic Oscillator | 22.17 | 6.62 |
Generation Income Properties Inc is an internally managed real estate investment company focused on acquiring and managing income-producing retail, office and industrial properties net leased to high-quality tenants in markets throughout the United States. Its key source of revenue is the rental income. The company holds properties in Alabama, Arizona, Colorado, the District of Columbia, Florida, Illinois, North Carolina and Virginia.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.